Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,808 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The International TREatment of ATopic Eczema (TREAT) Registry Taskforce: An Initiative to Harmonize Data Collection across National Atopic Eczema Photo- and Systemic Therapy Registries.
Spuls PI, Gerbens LAA, Apfelbacher CJ, Wall D, Arents BWM, Barbarot S, Roberts A, Deleuran M, Middelkamp-Hup MA, Vestergaard C, Weidinger S, Schmitt J, Irvine AD, Flohr C. Spuls PI, et al. Among authors: roberts a. J Invest Dermatol. 2017 Sep;137(9):2014-2016. doi: 10.1016/j.jid.2017.05.014. Epub 2017 May 27. J Invest Dermatol. 2017. PMID: 28558913 Free article. No abstract available.
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.
Gerbens LA, Boyce AE, Wall D, Barbarot S, de Booij RJ, Deleuran M, Middelkamp-Hup MA, Roberts A, Vestergaard C, Weidinger S, Apfelbacher CJ, Irvine AD, Schmitt J, Williamson PR, Spuls PI, Flohr C. Gerbens LA, et al. Among authors: roberts a. Trials. 2017 Feb 27;18(1):87. doi: 10.1186/s13063-016-1765-7. Trials. 2017. PMID: 28241851 Free PMC article.
TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo- and systemic therapy registries.
Gerbens LAA, Apfelbacher CJ, Irvine AD, Barbarot S, de Booij RJ, Boyce AE, Deleuran M, Eichenfield LF, Hof MH, Middelkamp-Hup MA, Roberts A, Schmitt J, Vestergaard C, Wall D, Weidinger S, Williamson PR, Flohr C, Spuls PI; international TREAT Registry Taskforce. Gerbens LAA, et al. Among authors: roberts a. Br J Dermatol. 2019 Apr;180(4):790-801. doi: 10.1111/bjd.16714. Epub 2018 Aug 3. Br J Dermatol. 2019. PMID: 29761486 Free PMC article.
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.
Bosma AL, Spuls PI, Garcia-Doval I, Naldi L, Prieto-Merino D, Tesch F, Apfelbacher CJ, Arents BWM, Barbarot S, Baselga E, Deleuran M, Eichenfield LF, Gerbens LAA, Irvine AD, Manca A, Mendes-Bastos P, Middelkamp-Hup MA, Roberts A, Seneschal J, Svensson Å, Thyssen JP, Torres T, Vermeulen FM, Vestergaard C, von Kobyletzki LB, Wall D, Weidinger S, Schmitt J, Flohr C. Bosma AL, et al. Among authors: roberts a. Br J Dermatol. 2020 Jun;182(6):1423-1429. doi: 10.1111/bjd.18452. Epub 2019 Nov 20. Br J Dermatol. 2020. PMID: 31444799
What is the evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis? A systematic review.
Blakeway H, Van-de-Velde V, Allen VB, Kravvas G, Palla L, Page MJ, Flohr C, Weller RB, Irvine AD, McPherson T, Roberts A, Williams HC, Reynolds N, Brown SJ, Paternoster L, Langan SM; (on behalf of UK TREND Eczema Network). Blakeway H, et al. Among authors: roberts a. Br J Dermatol. 2020 Sep;183(3):443-451. doi: 10.1111/bjd.18778. Epub 2020 Feb 11. Br J Dermatol. 2020. PMID: 31794059 Free PMC article. Review.
Atopic eczema and obesity: a population-based study.
Ascott A, Mansfield KE, Schonmann Y, Mulick A, Abuabara K, Roberts A, Smeeth L, Langan SM. Ascott A, et al. Among authors: roberts a. Br J Dermatol. 2021 May;184(5):871-879. doi: 10.1111/bjd.19597. Epub 2020 Dec 1. Br J Dermatol. 2021. PMID: 33090454
The sound of silence: where are the voices of patients in eczema guideline development?
Capozza K, Vastrup A, Proctor A, Roberts A, Picozza M, Manion R, Talent C, Hering M, Merhand S, Funk M, Tullos KZ, Arents BWM. Capozza K, et al. Among authors: roberts a. Br J Dermatol. 2022 Dec;187(6):1005-1006. doi: 10.1111/bjd.21822. Epub 2022 Sep 2. Br J Dermatol. 2022. PMID: 36052766 Free PMC article. No abstract available.
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.
Leshem YA, Chalmers JR, Apfelbacher C, Katoh N, Gerbens LAA, Schmitt J, Spuls PI, Thomas KS, Howells L, Williams HC, Simpson EL; Harmonising Outcome Measures for Eczema (HOME) initiative. Leshem YA, et al. JAMA Dermatol. 2022 Dec 1;158(12):1429-1435. doi: 10.1001/jamadermatol.2022.4211. JAMA Dermatol. 2022. PMID: 36223090
Routine infant skincare advice in the UK: A cross-sectional survey.
Goldsmith LP, Roberts A, Flohr C, Boyle RJ, Ussher M, Perkin MR. Goldsmith LP, et al. Among authors: roberts a. Clin Exp Allergy. 2024 Jan;54(1):56-60. doi: 10.1111/cea.14407. Epub 2023 Oct 11. Clin Exp Allergy. 2024. PMID: 37818752 No abstract available.
5,808 results